Outcomes of fulvestrant therapy among japanese women with advanced breast cancer: a retrospective multicenter cohort study (JBCRG-C06; Safari)

被引：0
|
作者：
H. Kawaguchi
N. Masuda
T. Nakayama
K. Aogi
K. Anan
Y. Ito
S. Ohtani
N. Sato
S. Saji
E. Tokunaga
S. Nakamura
Y. Hasegawa
M. Hattori
T. Fujisawa
S. Morita
M. Yamaguchi
T. Yamashita
Y. Yamamoto
S. Ohno
M. Toi
机构：
[1] Matsuyama Red Cross Hospital,Department of Breast Surgery
[2] NHO Osaka National Hospital,Department of Surgery, Breast Oncology
[3] Osaka Medical Center for Cancer and Cardiovascular Diseases,Department of Breast and Endocrine Surgery
[4] Shikoku Cancer Center,Department of Breast Oncology
[5] Kitakyushu Municipal Medical Center,Department of Surgery
[6] The Cancer Institute Hospital Of JFCR,Breast Medical Oncology Department
[7] Hiroshima City Hiroshima Citizens Hospital,Department of Breast Surgery
[8] Niigata Cancer Center Hospital,Department of Breast Oncology
[9] Fukushima Medical University,Department of Medical Oncology
[10] Kyushu Cancer Center,Department of Breast Oncology
[11] Showa University School of Medicine,Department of Surgery, Division of Breast Surgical Oncology
[12] Hirosaki Municipal Hospital,Department of Breast Surgery
[13] Aichi Cancer Center Hospital,Department of Breast Oncology
[14] Gunma Prefectural Cancer Center,Department of Breast Oncology
[15] Kyoto University Graduate School of Medicine,Department of Biomedical Statistics and Bioinformatics
[16] JCHO Kurume General Hospital,Department of Breast Surgery
[17] Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital,Department of Breast Surgery
[18] Kumamoto University,Department of Breast and Endocrine Surgery, Graduate School of Medical Sciences
[19] The Cancer Institute Hospital Of JFCR,Breast Oncology Center
[20] Graduate School of Medicine,Department of Breast Surgery
[21] Kyoto University,undefined
来源：
Breast Cancer Research and Treatment | 2017年 / 163卷
关键词：
Advanced; Breast cancer; Endocrine therapy; Fulvestrant; Metastatic; Treatment line;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：545 / 554
页数：9
相关论文
共 50 条
  • [1] Outcomes of fulvestrant therapy among japanese women with advanced breast cancer: a retrospective multicenter cohort study (JBCRG-C06; Safari)
    Kawaguchi, H.
    Masuda, N.
    Nakayama, T.
    Aogi, K.
    Anan, K.
    Ito, Y.
    Ohtani, S.
    Sato, N.
    Saji, S.
    Tokunaga, E.
    Nakamura, S.
    Hasegawa, Y.
    Hattori, M.
    Fujisawa, T.
    Morita, S.
    Yamaguchi, M.
    Yamashita, T.
    Yamamoto, Y.
    Ohno, S.
    Toi, M.
    BREAST CANCER RESEARCH AND TREATMENT, 2017, 163 (03) : 545 - 554
  • [2] Outcomes of fulvestrant therapy among Japanese women with ER-positive HER2-positive advanced or metastatic breast cancer: A subgroup analysis of the JBCRG-C06 safari study
    Hagi, Misato
    Kawaguchi, Hidetoshi
    Masuda, Norikazu
    Saji, Shigehira
    Yamamoto, Yutaka
    Nakayama, Takahiro
    Aogi, Kenjiro
    Anan, Keisei
    Ito, Yoshinori
    Ohtani, Shoichiro
    Sato, Nobuaki
    Takano, Toshimi
    Tokunaga, Eriko
    Nakamura, Seigo
    Hasegawa, Yoshie
    Hattori, Masaya
    Fujisawa, Tomomi
    Yamaguchi, Miki
    Yamashita, Hiroko
    Yamashita, Toshinari
    Yotsumoto, Daisuke
    Morita, Satoshi
    Toi, Masakazu
    Ohno, Shinji
    CANCER RESEARCH, 2020, 80 (04)
  • [3] Search for appropriate treatment strategy using fulvestrant for postmenopausal ER-positive advanced or recurrent breast cancer patients in Japan (JBCRG-C06; Safari)
    Kawaguchi, H.
    Masuda, N.
    Nakayama, T.
    Aogi, K.
    Anan, K.
    Ito, Y.
    Ohtani, S.
    Sato, N.
    Saji, S.
    Tokunaga, E.
    Nakamura, S.
    Hasegawa, Y.
    Hattori, M.
    Fujisawa, T.
    Morita, S.
    Yamaguchi, M.
    Yamashita, T.
    Yamamoto, Y.
    Ohno, S.
    Toi, M.
    EUROPEAN JOURNAL OF CANCER, 2016, 57 : S109 - S109
  • [4] Influence of the adjuvant hormonal therapy on hormone sensitivity and survival outcomes in ER+ and HER2-advanced breast cancer: A subgroup analysis of the JBCRG-C06 Safari study
    Nakayama, Takahiro
    Kawaguchi, Hidetoshi
    Masuda, Norikazu
    Aogi, Kenjiro
    Anan, Keisei
    Ito, Yoshinori
    Ohtani, Shoichiro
    Sato, Nobuaki
    Saji, Shigehira
    Takano, Toshimi
    Tokunaga, Eriko
    Nakamura, Seigo
    Hasegawa, Yoshie
    Hattori, Masaya
    Fujisawa, Tomomi
    Morita, Satoshi
    Yamaguchi, Miki
    Yamashita, Hiroko
    Yamashita, Toshinari
    Yamamoto, Yutaka
    Yotsumoto, Daisuke
    Toi, Masakazu
    Ohno, Shinji
    CANCER RESEARCH, 2020, 80 (04)
  • [5] Retrospective study on the effectiveness of medroxyprogesterone acetate in the treatment of ER-positive/HER2-negative post-menopausal advanced breast cancer: an additional analysis of the JBCRG-C06 Safari study
    Kawaguchi, Hidetoshi
    Yamamoto, Yutaka
    Saji, Shigehira
    Masuda, Norikazu
    Nakayama, Takahiro
    Aogi, Kenjiro
    Anan, Keisei
    Ohtani, Shoichiro
    Sato, Nobuaki
    Takano, Toshimi
    Tokunaga, Eriko
    Nakamura, Seigo
    Hasegawa, Yoshie
    Hattori, Masaya
    Fujisawa, Tomomi
    Morita, Satoshi
    Yamaguchi, Miki
    Yamashita, Toshinari
    Yotsumoto, Daisuke
    Toi, Masakazu
    Ohno, Shinji
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2023, 53 (03) : 203 - 211
  • [6] Retrospective study using database for the effectiveness of medroxyprogesterone acetate in patients with ER-positive/HER2-negative postmenopausal advanced breast cancer: An additional analysis of the JBCRG-C06 Safari study
    Utsunomiya, Kaho
    Kawaguchi, Hidetoshi
    Yamamoto, Yutaka
    Saji, Shigehira
    Masuda, Norikazu
    Nakayama, Takahiro
    Aogi, Kenjiro
    Anan, Keisei
    Ohtani, Shoichiro
    Sato, Nobuaki
    Takano, Toshimi
    Tokunaga, Eriko
    Nakamura, Seigo
    Hasegawa, Yoshie
    Hattori, Masaya
    Fujisawa, Tomomi
    Morita, Satoshi
    Yamaguchi, Miki
    Yamashita, Toshinari
    Yotsumoto, Daisuke
    Toi, Masakazu
    Ohno, Shinji
    CANCER RESEARCH, 2023, 83 (05)
  • [7] Factors associated with prolonged time to treatment failure with fulvestrant 500mg in patients with postmenopausal estrogen receptor-positive advanced/metastatic breast cancer (JBCRG-C06; Safari): A subgroup analysis
    Kawaguchi, H.
    Aogi, K.
    Masuda, N.
    Nakayama, T.
    Ito, Y.
    Ohtani, S.
    Sato, N.
    Takano, T.
    Saji, S.
    Tokunaga, E.
    Hasegawa, Y.
    Hattori, M.
    Fujisawa, T.
    Morita, S.
    Yamashita, H.
    Yamashita, T.
    Yamamoto, Y.
    Yotsumoto, D.
    Toi, M.
    Ohno, S.
    ANNALS OF ONCOLOGY, 2017, 28
  • [8] Fulvestrant with or without anti-HER2 therapy in patients in a postmenopausal hormonal state and with ER-positive HER2-positive advanced or metastatic breast cancer: A subgroup analysis of data from the Safari study (JBCRG-C06)
    Masuyama, Misato
    Masuda, Norikazu
    Kawaguchi, Hidetoshi
    Yamamoto, Yutaka
    Saji, Shigehira
    Nakayama, Takahiro
    Aogi, Kenjiro
    Anan, Keisei
    Ohtani, Shoichiro
    Sato, Nobuaki
    Takano, Toshimi
    Tokunaga, Eriko
    Nakamura, Seigo
    Hasegawa, Yoshie
    Hattori, Masaya
    Fujisawa, Tomomi
    Morita, Satoshi
    Yamaguchi, Miki
    Yamashita, Toshinari
    Yotsumoto, Daisuke
    Toi, Masakazu
    Ohno, Shinji
    CANCER MEDICINE, 2023, 12 (17): : 17718 - 17730
  • [9] Factors associated with prolonged time to treatment failure with fulvestrant 500 mg in patients with post-menopausal estrogen receptor-positive advanced breast cancer: a sub-group analysis of the JBCRG-C06 Safari study
    Kawaguchi, Hidetoshi
    Masuda, Norikazu
    Nakayama, Takahiro
    Aogi, Kenjiro
    Anan, Keisei
    Ito, Yoshinori
    Ohtani, Shoichiro
    Sato, Nobuaki
    Saji, Shigehira
    Takano, Toshimi
    Tokunaga, Eriko
    Nakamura, Seigo
    Hasegawa, Yoshie
    Hattori, Masaya
    Fujisawa, Tomomi
    Morita, Satoshi
    Yamaguchi, Miki
    Yamashita, Hiroko
    Yamashita, Toshinari
    Yamamoto, Yutaka
    Yotsumoto, Daisuke
    Toi, Masakazu
    Ohno, Shinji
    CURRENT MEDICAL RESEARCH AND OPINION, 2018, 34 (01) : 49 - 54
  • [10] Fulvestrant for the treatment of advanced breast cancer in postmenopausal women: A Japanese study
    Watanabe, T
    Sano, M
    Ohno, S
    Inaji, H
    Nishimura, R
    Shin, E
    Nomura, Y
    Morris, C
    ANTICANCER RESEARCH, 2004, 24 (2C) : 1275 - 1280
12345